ENTITY
Oneness Biotech

Oneness Biotech (4743 TT)

33
Analysis
Health Care • Taiwan
Oneness Biotech Co Ltd develops botanical new drugs and several biological-active new chemical entities that are purified and molecularly modified from these botanical sources.
more
Exchange Announcement • 13 Oct 2026 22:36

Bonvadis Topical Cream Received Medical Device Marketing Authorization Approval For All Indications In Wounds By Brazil Anvisa.

Exchange Announcement • 01 Oct 2026 18:35

The Medical Device Registration Application Of Bonvadis For All Indications In Wounds Has Been Accepted By Anpp In Algeria.

Exchange Announcement • 14 Aug 2026 18:30

The Phase Ii Clinical Trial Results Of Sns812, A Novel Sirna Drug For Covid-19, Have Been Published In The High-Impact Sci Journal, Journal Of Biomedical Science.

Exchange Announcement • 14 Aug 2026 17:16

Oneness Announces Information About The Second Investor Conference In 2026.

Exchange Announcement • 10 Aug 2026 17:31

The Company'S 2026q2 Consolidated Financial Statements Have Been Approved By The Board Of Directors

x